|PCORnet Network Affiliation|
|PCORnet Network Position||
Brandy Fureman is the Vice President of Research and New Therapies at the Epilepsy Foundation of America (EFA). Dr. Fureman directs all epilepsy research and new therapies initiatives of the Epilepsy Foundation. She is charged with growing the size and impact of the research program at the Foundation, consistent with the unmet needs of people with epilepsy and their families. She develops and maintains collaborative relationships with Epilepsy Foundation network leaders and with leaders of external research groups to form partnerships, to communicate and enhance the Foundation’s mission. She provides oversight of the Foundation’s research grant and new investigator programs, the PCORI-funded Rare Epilepsy Network and other clinical research studies, the work of the Epilepsy Innovation Institute and SUDEP Institute, and supervises the professional staff on the Research Team.
Prior to joining the EFA, Fureman was Program Director for Epilepsy in the Channels, Synapses and Circuits cluster at the National Institute of Neurological Disorders and Stroke (NINDS). Fureman was responsible for overseeing a diverse portfolio of epilepsy research awards, including clinical trials, translational projects, basic science research, and training grants that constituted over $40 million dollars of Federal investment in over 100 grants and cooperative agreements. She was also responsible for identifying epilepsy research issues critical to NINDS and NIH and taking programmatic action through creation of focused funding opportunities such as the Epilepsy Centers Without Walls program, resource development including the NINDS Common Data Elements for Epilepsy, Curing the Epilepsies conferences and multiple workshops to address the needs in the field. Fureman coordinated the Institute’s Epilepsy Research Benchmarks strategic planning process in collaboration with the American Epilepsy Society. While at NINDS, Fureman previously served as a Clinical Research Project Manager in the NINDS Clinical Trials Group where she was responsible for overseeing the NINDS Clinical Research Collaboration Network and a number of Data and Safety Monitoring Boards for Phase III clinical trials in epilepsy, head injury, and stroke rehabilitation.
She received her undergraduate degree in Genetic Engineering from Cedar Crest College, and her PhD in Neuroscience from the Department of Neuroscience and Anatomy at the Pennsylvania State University College of Medicine., where she focused on molecular and behavioral effects of ion channelopathy in episodic neurological disorders.
|Primary Institution Title||
Vice President, Research & New Therapies
Multisite clinical research, patient-reported outcomes, epilepsy